Tullis Growth Fund
Status
ACTIVE
Global HQ
Palo Alto, United States
Countries of investment
- USA
Investment stages
- Pre-Seed
- Seed
Industries
- Fintech
- AI
- Health Tech
- Internet
About
A growth-stage venture fund that invests in healthcare companies offering innovative solutions to improve patient care and operational efficiency.
A growth-stage venture fund that invests in healthcare companies offering innovative solutions to improve patient care and operational efficiency.
Investment Thesis
Focuses on investing in high-growth healthcare companies that are addressing key industry challenges through innovative products and services.
Portfolio
Amolyt Pharma
Anaconda Biomed
Apix Healthcare
CARDIOR Pharmaceuticals
Cyprium Therapeutics
Enthera
Eyevensys
Inflammasome Therapeutics
imCheck Therapeutics
Ixaltis
Keapstone Therapeutics
MedEdge
Metagenomi
Model Medicines
Noema Pharma
Pheon Therapeutics
Phoenicis Therapeutics
Profusa
PRISM BioLab
Protagenic Therapeutics
Rheos Medicines
Slingshot Bio
Visgenx
Wugen.